Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations - PubMed (original) (raw)

Comparative Study

doi: 10.2337/diabetes.50.2.322.

R J Ferry Jr, A Kelly, S Koo-McCoy, K Polonsky, B Glaser, M A Permutt, L Aguilar-Bryan, D Stafford, P S Thornton, L Baker, C A Stanley

Affiliations

Comparative Study

Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations

A Grimberg et al. Diabetes. 2001 Feb.

Abstract

Mutations in the high-affinity sulfonylurea receptor (SUR)-1 cause one of the severe recessively inherited diffuse forms of congenital hyperinsulinism or, when associated with loss of heterozygosity, focal adenomatosis. We hypothesized that SUR1 mutations would render the beta-cell insensitive to sulfonylureas and to glucose. Stimulated insulin responses were compared among eight patients with diffuse hyperinsulinism (two mutations), six carrier parents, and ten normal adults. In the patients with diffuse hyperinsulinism, the acute insulin response to intravenous tolbutamide was absent and did not overlap with the responses seen in either adult group. There was positive, albeit significantly blunted, acute insulin response to intravenous dextrose in the patients with diffuse hyperinsulinism. Graded infusions of glucose, to raise and then lower plasma glucose concentrations over 4 h, caused similar rises in blood glucose but lower peak insulin levels in the hyperinsulinemic patients. Loss of acute insulin response to tolbutamide can identify children with diffuse SUR1 defects. The greater response to glucose than to tolbutamide indicates that ATP-sensitive potassium (KATP) channel-independent pathways are involved in glucose-mediated insulin release in patients with diffuse SUR1 defects. The diminished glucose responsiveness suggests that SUR1 mutations and lack of KATP channel activity may contribute to the late development of diabetes in patients with hyperinsulinism independently of subtotal pancreatectomy.

PubMed Disclaimer

Figures

Similar articles

Cited by

References

    1. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2000;82:F79–F86. - PMC - PubMed
    1. Stanley CA. Hyperinsulinism in infants and children. Pediatr Clin North Am. 1997;44:363–374. - PubMed
    1. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matchinsky FM, Herold KC. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998;338:226–230. - PubMed
    1. Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338:1352–1357. - PubMed
    1. Thornton PS, Satin-Smith MS, Herold K, Glaser B, Chiu KC, Nestorowicz A, Permutt MA, Baker L, Stanley CA. Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr. 1998;132:9–14. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources